2024-05-16T10:17:40-05:00 2023-12-31 204126128 LACHMAN & LACHMAN LLP 444 MADISON AVENUE SUITE 301 NEW YORK NY 10022 990 2023-01-01 134171637 FUND FOR OPHTHALMIC KNOWLEDGE INC C/O DAVID H ABRAMSON MD FUND 2127441700 101 CENTRAL PARK WEST NEW YORK NY 10023 DAVID H ABRAMSON MD PRESIDENT 2127441700 2024-05-16 1 DAVID ABRAMSON MD 999009999 0 PAUL LACHMAN P01478565 2123718319 2024-05-10 X 2 AAL1 IAL1 2023 2023-04-26 12:10:37Z DAVID H ABRAMSON MD 101 CENTRAL PARK WEST NEW YORK NY 10023 476923 0 X WWW.FUNDFOROPHTHALMICKNOWLEDGE.ORG X 2001 NY SEE STATEMENT ON SCHEDULE O 5 5 0 0 0 0 45332 34922 0 0 59308 17218 0 0 104640 52140 242738 247857 0 0 0 0 0 0 0 12581 4782 255319 252639 -150679 -200499 965576 814715 99999 70975 865577 743740 X SEE STATEMENT ON SCHEDULE O 0 0 198692 198692 MEMORIAL SLOAN-KETTERING CANCER CENTER ("MSKCC") ($198,692) - SUPPORTED RESEARCH ON EYE CANCER PERFORMED AT MSKCC: STUDIES ON CELL FREE DNA IN PLASMA OF RETINOBLASTOMA PATIENTS, STUDIES OF CHOROIDAL INVASION IN RETINOBLASTOMA, STUDIES OF THE USE OF INTRAARTERIAL CHEMOTHERAPY IN HISTIOCYTOSIS, STUDIES ON EFFICACY AND TOXICITY OF INTRAVITREAL TOPOTECAN FOR EYE CANCER. 29811 29811 MEETINGS AND EDUCATIONAL SUPPORT ($29,811) - TRAVEL, LODGING, AND BOARDING FOR MSK ATTENDINGS, MSK TECHNICIAN, INTERNS AND SUPPORT FOR SCIENTIFIC MEETINGS. 10000 10000 MACULA SOCIETY EDUCATIONAL FUND ($10,000) - TO FUND VARIOUS EDUCATIONAL INITIATIVES. 7500 7500 FUNDACION NATALI DAFNE FLEXER ($7,500) - SUPPORT CLINIC & MOLECULAR STUDIES OF RETINOBLASTOMA RESEARCH UNDER DIRECT OF DR. GUILLERMO CHANTADA, MD. PHD. THIS SUPPORTS RETINOBLASTOMA RESEARCH IN ARGENTINA AND SPAIN INCLUDING SUPPORT FOR LAB PERSONNEL, ATTENDANCE AT MEETINGS, SUPPLIES AND PUBLICATION. 1854 1854 RYR-1 FOUNDATION ($1,854) - TO FURTHER RYR-1 FOUNDATION'S MISSION OF INCREASING AWARENESS OF RYR-1 MYOPATHY, SUPPORTING RESEARCH, AND HELPING TO FIND A CURE. 9354 9354 247857 1 1 0 0 0 0 0 0 0 0 1 1 0 0 1 0 0 0 0 0 0 1 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X 5 5 1 0 0 0 0 0 0 1 0 0 0 1 1 1 1 1 1 0 0 0 NY X FUND FOR OPHTHALMIC KNOWLEDGE INC 2127441700 101 CENTRAL PARK WEST NEW YORK NY 10023 X DAVID H ABRAMSON MD DIRECTOR & PRESIDENT 1.00 X X 0 0 0 ALLAN ABRAMSON MD DIRECTOR 0.30 X 0 0 0 NICHOLAS GRUMBACH MD DIRECTOR 0.20 X 0 0 0 HILARY CRUZ-ABRAMS BAMPHRN DIRECTOR & TREASURER 0.20 X X 0 0 0 JOSEPH GOLD MD DIRECTOR 0.20 X 0 0 0 0 0 0 0 0 0 0 0 34922 34922 15172 15172 426829 424783 2046 2046 2046 52140 0 0 17218 210546 210546 29811 29811 7500 7500 701 701 1183 1183 638 638 RESEARCH EXPENSES 1000 1000 STATE FILING FEES 692 692 FOREIGN TAX 568 568 252639 247857 4782 0 127307 82374 9768 10443 8580 2501 1863 826000 730478 0 0 965576 814715 99999 70975 99999 70975 X 865577 743740 865577 743740 965576 814715 -200499 78662 0 X X 0 0 0 X 50727 10786 17115 20332 9922 108882 50727 10786 17115 20332 9922 108882 26210 82672 21239 15814 27703 24722 14547 104025 212907 0.38830 0.38180 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 10443 8580 1863 1863 PUBLICLY TRADED SECURITIES 730478 F 730478 CREDIT CARD PAYABLE 70850 STATE FILING FEE 125 70975 1 0 0 0 0 0 0 0 0 0 SOUTH AMERICA - ARGENTINA FUNDACION NATALI DAFNE FLEXER - SUPPORT CLINIC & MOLECULAR STUDIES OF RETINOBLASTOMA RESEARCH UNDER DIRECT OF DR. GUILLERMO CHANTADA, MD. PHD. THIS SUPPORTS RETINOBLASTOMA RESEARCH IN ARGENTINA AND SPAIN INCLUDING SUPPORT FOR LAB PERSONNEL, ATTENDANCE AT MEETINGS, SUPPLIES AND PUBLICATION. 7500 EFT 0 BOOK 1 0 0 0 0 0 0 1 MEMORIAL SLOAN KETTERING CANCER CENTER 1275 YORK AVENUE NEW YORK NY 10065 131624182 501(C)(3) 198692 0 BOOK SUPPORTED RESEARCH ON EYE CANCER PERFORMED AT MSKCC: STUDIES ON CELL FREE DNA IN PLASMA OF RETINOBLASTOMA PATIENTS, STUDIES OF CHOROIDAL INVASION IN RETINOBLASTOMA, STUDIES OF THE USE OF INTRARTERIAL CHEMOTHERAPY IN HISTIOCYTOSIS, STUDIES ON EFFICACY AND TOXICITY OF INTRAVITREAL TOPOTECAN FOR EYE CANCER. 1 TRAVEL, LODGING, AND BOARDING FOR MSK ATTENDINGS, MSK TECHNICIAN, INTERNS AND SUPPORT FOR SCIENTIFIC MEETINGS. 7 29811 BOOK AIRFARE, LODGING AND RESEARCH SUPPLIES EXPENSES WERE PAID DIRECTLY BY THE ORGANIZATION FOR SCIENTIFIC MEETINGS. PART I, LINE 2: THE ORGANIZATION MONITORS THE USE OF THE GRANT FUNDS IN THE UNITED STATES BY REQUESTING REPORTS FROM THE RECIPIENTS OF THE GRANTS. FORM 990, PART VI, SECTION A, LINE 2 DAVID H. ABRAMSON, M.D. AND ALLAN ABRAMSON, M.D. ARE BROTHERS. HILARY CRUZ-ABRAMS IS THE DAUGHTER OF DAVID H. ABRAMSON, M.D.. FORM 990, PART VI, SECTION A, LINE 8B THE ORGANIZATION DOES NOT MAINTAIN INDIVIDUAL COMMITTEES OF THE BOARD. ALL ACTIONS ARE REVIEWED BY THE FULL BOARD. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 WILL BE DISTRIBUTED TO THE MEMBERS OF THE BOARD OF DIRECTORS AS A MATTER OF POLICY PRIOR TO IT'S BEING FILED. BOARD MEMBERS ARE REQUIRED TO REVIEW AND APPROVE THE FORM 990 WITHIN SEVEN DAYS OF RECEIPT. ANY QUESTIONS RAISED ARE FORWARDED TO THE ACCOUNTANT FOR RESOLUTION. FORM 990, PART VI, SECTION B, LINE 12C TO ENSURE THAT THE FUND OPERATES IN A MANNER CONSISTENT WITH ITS CHARITABLE PURPOSES AND DOES NOT ENGAGE IN ACTIVITIES THAT COULD JEOPARDIZE ITS TAX-EXEMPT STATUS, ALL OFFICERS AND DIRECTORS ARE REQUIRED TO COMPLETE CONFLICT OF INTEREST QUESTIONNAIRE ANNUALLY WHICH IS REVIEWED BY THE BOARD TO ENSURE NO CONFLICTS EXIST. FORM 990, PART VI, SECTION B, LINE 15 NO COMPENSATION HAS BEEN MADE TO ANY OFFICERS TO DATE. FORM 990, PART VI, SECTION C, LINE 19 THE FOUNDATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON WRITTEN REQUEST. FORM 990, PART XII, LINE 2C THE PROCESS HAS NOT CHANGED FROM PRIOR YEARS. FORM 990, PART I, LINE 1 & PART III, LINE 1: THE FUND FOR OPHTHALMIC KNOWLEDGE, INC. (THE FUND) IS A NOT-FOR-PROFIT ORGANIZATION INCORPORATED IN THE STATE OF DELAWARE UNDER THE NOT-FOR-PROFIT CORPORATION LAW AND IS EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. RESEARCH: THE FUND WAS ESTABLISHED TO SUPPORT BASIC RESEARCH, CLINICAL RESEARCH AND CLINICAL TRIALS BY FUNDING SCIENTISTS, CLINICAL RESEARCHERS, TECHNICIANS AND/OR STUDENTS WHO WORK UNDER THE SUPERVISION OF FACULTY MEMBERS OF MEDICAL SCHOOLS OR TEACHING HOSPITALS, OR ARE EMPLOYEES OF RESEARCH LABORATORIES. PROFESSIONAL EDUCATION: THE FUND SUPPORTS EFFORTS THAT EDUCATE AND TRAIN TECHNICIANS, MEDICAL STUDENTS, PHYSICIANS, NURSES AND NURSES IN TRAINING, SCIENTISTS-IN-TRAINING, POST-DOCTORAL AND POST-GRADUATE FELLOWS IN OPHTHALMOLOGY AND OTHER AREAS OF MEDICINE. IT SUPPORTS THE COORDINATION OF MEDICAL KNOWLEDGE IN FIELD RELATED TO OPHTHALMOLOGY INCLUDING MEDICINE, PEDIATRICS, SURGERY RADIATION ONCOLOGY, PATHOLOGY, GENETICS AND NEUROSURGERY, PUBLIC EDUCATION: THE FUND SUPPORTS EDUCATIONAL EFFORTS DIRECTED AT THE GENERAL PUBLIC THROUGH THE USE OF ORAL AND WRITTEN MATERIAL AND VIDEO IN ENGLISH AND OTHER LANGUAGES IN ADDITION TO COMPUTER BASED LEARNING AND INTERNET BASED DISSEMINATION OF KNOWLEDGE. TECHNOLOGY: THE FUND SUPPORTS THE INITIATION, DEVELOPMENT, INTEGRATION, AND USE OF NEW TECHNOLOGY IN OPHTHALMOLOGY AND OTHER FIELDS OF MEDICINE THAT ARE USED IN THE DIAGNOSIS, DOCUMENTATION, TREATMENT, OR GENETIC UNDERSTANDING OF DISEASES. THE FUND MAY OFFER A SCHOLARSHIP TO ASSIST MEDICAL STUDENTS, DOCTORAL STUDENTS, DOCTORS-IN-TRAINING AND NURSES WITH EDUCATIONAL EXPENSES INCURRED ATTENDING COURSES OR CONFERENCES. THE SELECTION CRITERIA WILL BE OBJECTIVE AND NON-DISCRIMINATORY.